| 🎄 Our Christmas Morning Gift: Our Top Stock Picks for 2026 – Just $20! | While most investors are focused on what just happened in 2025, the real money is made by positioning before the next big rotation takes hold. | That's exactly why we just released our Top Stocks Picks for 2026 report — a curated list of names positioned to benefit from rate stabilization, sector rotation, and powerful long-term trends heading into the New Year. | To give you a taste of what's inside, here's a sneak inside the report: | A Turnaround Pharma Play with Income + Upside | Bristol-Myers Squibb (BMY) is a household pharma name that's been left for dead — until now. | As capital rotates away from high-multiple growth and toward cash-generating, dividend-supported equities, BMY is starting to shine. The stock has reclaimed its 200-month moving average and broken back above a long-term trendline stretching back more than a decade. | 📈 Our analysis shows: | | This is the kind of overlooked rotation play we love heading into 2026. | If you'd like to be one of the first to unlock the rest of our stock picks, click below now: | Access Schaeffer's Stock Picks for 2026 | | Merry Christmas, | | Bernie Schaeffer | Founder & CEO | Schaeffer's Investment Research | 📧 service@sir-inc.com | 🌐 http://www.schaeffersresearch.com | 📞1-800-448-2080 | International 1-513-589-3800 |
|
0 التعليقات:
إرسال تعليق